Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240718062454N2Phase 3Completed
Phase 3, randomised, double-blind trial of ketamine in shoulder pain, sponsored by Guilan University of Medical Sciences. Primary endpoint: Shoulder pain during and after surgery. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240718062454N2.